Generic Effexor XR Could Hit Antidepressant Market By June 2008
This article was originally published in The Pink Sheet Daily
Executive Summary
Wyeth and Teva settle patent infringement suit; Teva believes it holds 180-day exclusivity for generic extended-release venlafaxine.
You may also be interested in...
Effexor XR To Go Generic In 2010 Under Settlement Between Teva and Wyeth
The deal could give Wyeth more breathing room to launch its follow-on antidepressant.
Effexor XR To Go Generic In 2010 Under Settlement Between Teva and Wyeth
The deal could give Wyeth more breathing room to launch its follow-on antidepressant.
Wyeth Set To File NDA For Antipsychotic Bifeprunox In 2006
Wyeth has partnered with Solvay to structure a development plan for the atypical antipsychotic.